Drawing for ALLEREASE

USPTO serial 75130287

ALLEREASE

Reviewed by CopyMark Law Group

Reg. 2067190Status 713
Filing date
Status date
Registration date
Jun 3, 1997
Examiner
MICHOS, JOHN E
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALLEREASE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005homeopathic medication for allergy and sinus reliefSECTION 18 - CANCELLEDMay 1, 1995

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 21, 2002CANTCANCELLATION TERMINATED NO. 999999
Feb 13, 2002C18.CANCELLED SECTION 18-TOTAL
Feb 13, 2002CANTCANCELLATION TERMINATED NO. 999999
Jul 5, 2001PETCCANCELLATION INSTITUTED NO. 999999
Jun 3, 1997R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 11, 1997PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 7, 1997NPUBNOTICE OF PUBLICATION
Dec 14, 1996CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 4, 1996DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance